These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 17176249

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB, Ørn S, Ng LL, Manhenke C, Shipley L, Aarsland T, Dickstein K.
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL.
    J Am Coll Cardiol; 2007 Apr 10; 49(14):1525-32. PubMed ID: 17418290
    [Abstract] [Full Text] [Related]

  • 5. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention.
    de Winter RJ, Stroobants A, Koch KT, Bax M, Schotborgh CE, Mulder KJ, Sanders GT, van Straalen JP, Fischer J, Tijssen JG, Piek JJ.
    Am J Cardiol; 2004 Dec 15; 94(12):1481-5. PubMed ID: 15589000
    [Abstract] [Full Text] [Related]

  • 6. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.
    Eur Heart J; 2009 May 15; 30(9):1057-65. PubMed ID: 19168526
    [Abstract] [Full Text] [Related]

  • 7. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A, Narain VS, Mehrotra S, Dwivedi SK, Saran RK, Puri VK.
    Indian Heart J; 2005 May 15; 57(4):304-10. PubMed ID: 16350675
    [Abstract] [Full Text] [Related]

  • 8. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
    Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G.
    Crit Care Med; 2007 Oct 15; 35(10):2268-73. PubMed ID: 17717488
    [Abstract] [Full Text] [Related]

  • 9. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
    Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton C, Turner J, Crozier IG, Yandle TG.
    Circulation; 2003 Jun 10; 107(22):2786-92. PubMed ID: 12771003
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
    James SK, Lindahl B, Timmer JR, Ottervanger JP, Siegbahn A, Stridsberg M, Armstrong P, Califf R, Wallentin L, Simoons ML.
    Am J Cardiol; 2006 Jan 15; 97(2):167-72. PubMed ID: 16442356
    [Abstract] [Full Text] [Related]

  • 12. Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction.
    Palmer BR, Pilbrow AP, Frampton CM, Yandle TG, Skelton L, Nicholls MG, Richards AM.
    Eur Heart J; 2008 Oct 15; 29(20):2489-96. PubMed ID: 18757359
    [Abstract] [Full Text] [Related]

  • 13. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis.
    Suzuki S, Yoshimura M, Nakayama M, Mizuno Y, Harada E, Ito T, Nakamura S, Abe K, Yamamuro M, Sakamoto T, Saito Y, Nakao K, Yasue H, Ogawa H.
    Circulation; 2004 Sep 14; 110(11):1387-91. PubMed ID: 15353502
    [Abstract] [Full Text] [Related]

  • 14. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
    Yu H, Oswald H, Gardiwal A, Lissel C, Klein G.
    Am J Cardiol; 2007 Aug 15; 100(4):635-9. PubMed ID: 17697820
    [Abstract] [Full Text] [Related]

  • 15. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.
    Am J Cardiol; 2007 Nov 15; 100(10):1571-6. PubMed ID: 17996522
    [Abstract] [Full Text] [Related]

  • 16. Changes in the Doppler myocardial performance index during dobutamine echocardiography: association with neurohormonal activation and prognosis after acute myocardial infarction.
    Nørager B, Husic M, Møller JE, Bo Hansen A, Pellikka PA, Egstrup K.
    Heart; 2006 Aug 15; 92(8):1071-6. PubMed ID: 16387817
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S, Manhenke C, Squire IB, Ng L, Anand I, Dickstein K.
    J Card Fail; 2007 Dec 15; 13(10):843-9. PubMed ID: 18068618
    [Abstract] [Full Text] [Related]

  • 19. Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans.
    Khan SQ, Bhandari SS, Quinn P, Davies JE, Ng LL.
    Int J Cardiol; 2007 May 02; 117(3):323-8. PubMed ID: 16887216
    [Abstract] [Full Text] [Related]

  • 20. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D, Schouten O, Boersma E, Welten GM, Dunkelgrun M, Lindemans J, van Gestel YR, Hoeks SE, Bax JJ, Poldermans D.
    Am J Cardiol; 2008 Jan 01; 101(1):122-6. PubMed ID: 18157978
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.